Module 9 2024

03/09/2024

Concluding Remarks (2)

⚫ Technical

– Data as for biotech/biological

– But as combination vaccines and include other components like adjuvants (which have own

production), technical data often complex

⚫ As such LCM is a significant supply challenge for Vx which is made more complex by long life cycles

⚫ Despite the challenges, vaccines are fantastic products to be involved with!

⚫ And they are evolving into new modalities and indications

The Organisation for Professionals in Regulatory Affairs

53

Vaccines are one of the greatest achievements of public health 1

1. MMWR 1999;48:241 – 243

The Organisation for Professionals in Regulatory Affairs

54

27